CARLSBAD, Calif. & SUZHOU, China--(BUSINESS WIRE)--
EBD Group, the leading partnering firm for the life science industry,
and ChinaBio® LLC, a leading consulting firm in Shanghai, will host
ChinaBio® Partnering Forum 2012 at the Kempinski Hotel Suzhou, May 23?24
in Suzhou, China. A special Partnering Bootcamp, a half-day
pre-conference program sponsored by Cooley LLP, will be held on Tuesday,
May 22 prior to the opening reception.
The special afternoon program, called "Partnering Bootcamp: How to
Partner with Global Pharma," is designed to be a practical "how to"
session for new or experienced entrepreneurs launching their life
science business in China. The bootcamp will offer advice and practical
tips for protecting intellectual property, and foster discussion on
developing partnerships with international pharma.
"We are pleased to have the opportunity to host this special program to
share our expertise in advising global life sciences companies on issues
ranging from venture capital and private equity to IP strategy and
partnering," said Patrick Loofbourrow, a Shanghai Partner with Cooley
LLP. "The bootcamp will jump start the week for delegates and may even
change their long-term business agendas."
Bootcamp speakers will discuss specific points on dealmaking in China,
including what to expect from a partnering relationship and how to meet
and impress potential partners. They will also consider trends in
licensing and partnering transactions in China's growing life science
The pre-conference program continues with "Optimizing your business in
China" with Cooley LLP Partners Lila Hope and Nan Wu from Palo
Alto/Shanghai and San Francisco/San Diego, respectively. The speakers
will discuss the challenges in launching a life science business in
China, from the first in-license at a company's formation to partnering
"Cooley LLP has been the leading law firm in the life sciences arena,"
said Lila Hope. "We have decades of industry knowledge and deal
experience helping our life sciences clients at the most critical
junctures such as licensing, discovery collaborations, product
partnering, financing, public offering and M&A. We are also there on a
day-to-day basis counseling on patents, corporate, tax, employment,
antitrust and regulatory matters. I am looking forward to sharing my
experience and exchanging ideas with the bootcamp participants on the
intricacy of life sciences deal-making."
"Cooley's life science patent practice is uniquely suited for cross
border deals as a number of attorneys in the group have advanced
technical degrees and are bilingual," said Nan Wu. "Working alongside
Chinese associates, we have been carrying out a considerable amount of
patent filings and portfolio management in China on behalf of both US
and Chinese life science companies."
"What to expect from a partnering relationship," will cover what to look
for in a partner in China to what those partners are looking for in
return. The panel features speakers Lila Hope, Greg B. Scott, President
and Founder of ChinaBio® LLC, and Jimmy Z. Zhang, Worldwide Licensing &
Acquisitions with Merck & Co., Inc.
"Partnering is a critical part of business development and certainly is
one of the most important steps your company will take. It should be
carefully planned and executed," said Zhang. "The key to China is in
understanding the finer complexities ranging from licensing to
co-development and distribution channels. This panel really echoes the
theme of the conference; relationships are the key ingredient to
creating a presence in China. "
The focus on partnering continues in a third panel, "How to meet and
impress potential partners" with speaker Martina Molsbergen, CEO of C14
Consulting Group, that is designed to guide delegates in maximizing
their experience at ChinaBio®Partnering Forum 2012. Molsbergen will
review features of EBD Group's powerful partneringONE® system that allow
companies to present their projects, screen potential partners, and set
up meetings during the conference. partneringONE® enables delegates to
efficiently identify, meet and network with companies from across the
life science value chain.
ChinaBio® Partnering Forum is the premier life science partnering event
in China. Held in Suzhou, China, the event will attract biotech and
pharma leaders from around the world along with hundreds of China-based
developers of novel technologies for two days of productive partnering.
Online registration for the conference will close on May 17, 2012,
5:00 PM PDT, after which all registrations will be handled on site.
Information on the conference and registration details can be found
online at www.ebdgroup.com/cbpf/registration.
About EBD Group
EBD Group is the leading partnering firm for the global life science
industry. Since 1993, biotech, pharma and medical device companies have
leveraged EBD Group's partnering conferences, technology and services to
identify business opportunities and develop strategic relationships
essential to their success. EBD Group's conferences are run with the
support of leading corporations and international trade associations and
Spring®, Europe's largest life science partnering conferences,
supported by the Biotechnology Industry Organization (BIO)
America?, the fastest growing partnering event in North America
EBD Group's partnering event for the innovative medical technology
Europe, the investor conference co-organized with BioCentury
Publications and BIO
Partnering Forum, the first dedicated biotech/pharma partnering
conference in China, co-produced with ChinaBio® LLC
for Global Impact®, a new partnering conference providing an
innovative forum to partner, identify and generate social and
philanthropic investment and funding opportunities
Showcase?, a unique forum in San Francisco for presenting to
investors and business development executives, co-produced with
Demy-Colton Life Science Advisors
EBD Group's sophisticated web-based partnering service, partneringONE®,
is used as the partnering engine at numerous third-party events around
the world, and partnering360® is the open
online community of life science dealmakers that enhances partnering
experiences throughout the year. Outside of the conference format, EBD
Group's consultants provide hands-on assistance for firms seeking to in-
or out-license products and technologies.
EBD Group has offices in the USA and Europe.
Additional links and information:
Follow EBD Group on Twitter: twitter.com/ebdgroup
More information is available at www.ebdgroup.com.
About ChinaBio® LLC
Since its founding in January, 2007, ChinaBio® LLC has rapidly created a
broad platform of capabilities connecting China life science with the
world. ChinaBio has helped global life science companies identify over
400 licensing and acquisition opportunities in China and China companies
raise over USD 450 million.
Conferences: ChinaBio organizes the premier life science investment
and partnering conferences in China, having attracted over 4,000
Consulting: ChinaBio works with global life science companies and
China entrepreneurs to define and execute a successful global strategy.
Capital: ChinaBio helps companies secure partnerships and acquisitions
and access private and government funding in China.
Publishing: ChinaBio® Today is the most widely read online and
email newsletter on China's life science industry, with over 18,000
More information is available at www.chinabiollc.com.